Avelumab Program Rollover Study

NCT03815643 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Avelumab

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]